EUVIMEDEUVIMED entdecken
Crossref

Recent HIV-1 infection and pre-treatment HIV drug resistance among adults initiating antiretroviral therapy in rural Tanzania

Alex J Ntamatungiro iD, Joel M Francis iD, Dorcas Mnzava, Robert Ndege iD, Prosper S Njau, James Okuma, Fiona Vanobberghen, Daniel H Paris iD, Juliana Kagura, Maja Weisser

International Journal of STD & AIDS · 2025

DOI: 10.1177/09564624251409692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2025. Verfasst von Alex J Ntamatungiro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology and Biostatistics, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Drug Resistance, Viral, Anti-HIV Agents. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Carnegie Corporation of New York, SIDA, Uppsala Monitoring Centre and the DELTAS Africa Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

New HIV-1 infections continue to pose a major challenge to ending the HIV epidemic and may facilitate the transmission of drug-resistant strains. In this study, we aimed to determine the proportion of recent HIV-1 infections (RHI) among individuals initiating HIV care at a rural referral hospital in Tanzania and to assess the prevalence of pre-treatment HIV-1 drug resistance (PDR) and circulating subtypes among those with RHI.

Methods

In this cross-sectional analysis, RHI was identified using the Asante HIV-1 rapid recency assay on bio-banked samples from newly diagnosed adult people living with HIV (PLHIV) enrolled in the Kilombero and Ulanga Antiretroviral cohort between March 2019 and March 2022. Risk factors for recent HIV were evaluated using logistic regression analysis. Genotypic resistance testing (GRT) using Sanger sequencing was performed on samples from people with RHI.

Results

Among 599 PLHIV, 24 (4%) were identified with RHI. No factors were found to be associated with RHI. Genotypic resistance testing was successful in 16 of the 24 (67%) participants, of whom 5 (31%) harbored HIV-1 drug resistance mutations: 4/16 (25%) for non-nucleoside reverse transcriptase inhibitors, 2/16 (13%) for nucleoside reverse transcriptase inhibitors, and 1/16 (6%) for protease inhibitors.

Conclusion

The low prevalence of RHI in this hospital-based study suggests a high rate of late HIV diagnosis. Despite the limited sample size, the notable proportion of people with recent infection who had drug resistance highlights a serious public health concern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV-1Drug Resistance, ViralAnti-HIV AgentsHumansTanzaniaMaleAdultFemaleCross-Sectional StudiesRural PopulationPrevalenceGenotypeMiddle AgedRisk Factors

Stichwörter der Autor:innen

Tanzaniaantiretroviral therapydrug resistancerecent HIV infection

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Division of Epidemiology and Biostatistics, University of the Witwatersrand, Johannesburg, South Africa.
  • Biomedical Research and Clinical Trials, Ifakara Health Institute, Ifakara, Tanzania.
  • Department of Family Medicine and Primary Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Saint Francis Regional Referral Hospital, Ifakara, Tanzania.
  • Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
  • University of Basel, Basel, Switzerland.

ORCID-Profile: Alex J Ntamatungiro, Joel M Francis, Robert Ndege, Daniel H Paris

Förderung

  • Carnegie Corporation of New York
  • SIDA
  • Uppsala Monitoring Centre and the DELTAS Africa Initiative
  • African Academy of Sciences (AAS)’s Alliance for Accelerating Excellence in Science in Africa
  • Africa’s Development Planning and Coordinating Agency
  • Integrated Diagnostic and Sequencing Platform

Zitieren

APA

Ntamatungiro, A. J., Francis, J. M., Mnzava, D., Ndege, R., Njau, P. S., Okuma, J., Vanobberghen, F., Paris, D. H., Kagura, J., & Weisser, M. (2025). Recent HIV-1 infection and pre-treatment HIV drug resistance among adults initiating antiretroviral therapy in rural Tanzania. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251409692

Vancouver

Ntamatungiro AJ, Francis JM, Mnzava D, Ndege R, Njau PS, Okuma J, et al. Recent HIV-1 infection and pre-treatment HIV drug resistance among adults initiating antiretroviral therapy in rural Tanzania. International Journal of STD & AIDS. 2025. doi:10.1177/09564624251409692

BibTeX
@article{Ntamatungiro2025,
  author = {Ntamatungiro, Alex J and Francis, Joel M and Mnzava, Dorcas and Ndege, Robert and Njau, Prosper S and Okuma, James and Vanobberghen, Fiona and Paris, Daniel H and Kagura, Juliana and Weisser, Maja},
  title = {Recent HIV-1 infection and pre-treatment HIV drug resistance among adults initiating antiretroviral therapy in rural Tanzania},
  journal = {International Journal of STD & AIDS},
  year = {2025},
  doi = {10.1177/09564624251409692}
}
Kostenlos starten →